A new clinical study sponsored by Chr. Hansen and conducted in cooperation with a hospital and the University of Milan documents that supplementation with either of the strains BB-12 or L. casei
431 may improve the body’s resistance to common infections such as flu and colds.
The randomized, double-blind, placebo-controlled study included 211 healthy adults and investigated the impact of Chr. Hansen’s probiotic strains BB-12 and L. casei 431 on the functional capacity of the immune system by measuring specific antibody responses to an influenza vaccination. Study results showed the antibody responses were significantly increased in both probiotic groups compared to placebo. For further information: www.chr-hansen.com